The largest prospective warfarin-treated cohort supports genetic forecasting

Genetic variants of cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) are known to influence warfarin dose, but the effect of other genes has not been fully elucidated. We genotyped 183 polymorphisms in 29 candidate genes in 1496 Swedish patients starting warfarin treatment, and...

Full description

Saved in:
Bibliographic Details
Main Authors: Wadelius, Mia, Chen, Leslie Y., Lindh, Jonatan D., Eriksson, Niclas, Ghori, Mohammed J. R., Bumpstead, Suzannah, Holm, Lennart, McGinnis, Ralph, Rane, Anders, Deloukas, Panos
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2009
Subjects:
Clinical Trials and Observations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2630264/
https://ncbi.nlm.nih.gov/pubmed/18574025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-04-149070
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items